This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Mylan homes in on EU approval for Meda deal by late July

By Dafydd Nelson ( June 21, 2016, 16:27 GMT | Comment) -- Generic drugmaker Mylan can expect to receive EU approval to buy Swedish rival Meda before the end of next month. The European Commission currently has until July 6 to rule on the deal, though that deadline could get pushed back by two weeks if Mylan offers to revise the takeover to ease concerns at the regulator in Brussels.Generic drugmaker Mylan can expect to receive EU approval to buy Swedish rival Meda before the end of next month....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login